GeneDx Total Assets from 2010 to 2026

WGS Stock

94.78 3.54 3.88%

GeneDx Holdings Total Assets yearly trend continues to be comparatively stable with very little volatility. Total Assets will likely drop to about 481.6 M in 2026. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2020-12-31

Previous Quarter

463.9 M

Current Value

493.9 M

Quarterly Volatility

178.2 M

Covid

Interest Hikes

Check GeneDx Holdings financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among GeneDx Holdings' main balance sheet or income statement drivers, such as Interest Income of 3.1 M, Depreciation And Amortization of 28.4 M or Interest Expense of 2.7 M, as well as many indicators such as Price To Sales Ratio of 5.59, Dividend Yield of 0.0 or PTB Ratio of 9.21. GeneDx financial statements analysis is a perfect complement when working with GeneDx Holdings Valuation or Volatility modules.

Build AI portfolio with GeneDx Stock

Check out the analysis of GeneDx Holdings Correlation against competitors.

The evolution of Total Assets for GeneDx Holdings Corp provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how GeneDx Holdings compares to historical norms and industry peers.

Latest GeneDx Holdings' Total Assets Growth Pattern

Below is the plot of the Total Assets of GeneDx Holdings Corp over the last few years. Total assets refers to the total amount of GeneDx Holdings assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in GeneDx Holdings Corp books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. GeneDx Holdings' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in GeneDx Holdings' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 419.38 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

GeneDx Total Assets Regression Statistics

	Arithmetic Mean	333,496,944
	Geometric Mean	316,200,803
	Coefficient Of Variation	35.63
	Mean Deviation	105,929,927
	Median	251,642,000
	Standard Deviation	118,830,201
	Sample Variance	14120.6T
	Range	302.5M
	R-Value	0.77
	Mean Square Error	6167.2T
	R-Squared	0.59
	Significance	0.0003
	Slope	18,083,525
	Total Sum of Squares	225929.9T

GeneDx Total Assets History

	2026	481.6 M
	2025	482.3 M
	2024	419.4 M
	2023	418.8 M
	2022	545.3 M
	2021	554.1 M

Other Fundumenentals of GeneDx Holdings Corp

Intangibles To Total Assets

GeneDx Holdings Total Assets component correlations

	Net Tangible Assets	Retained Earnings	Accounts Payable	Net Receivables	Deferred Long Term Liab	Total Current Assets	Property Plant Equipment	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Long Term Debt	Total Liab	Net Invested Capital	Short Long Term Debt	Net Working Capital	Short Term Debt	Common Stock	Long Term Debt Total	Capital Surpluse	Intangible Assets
Net Tangible Assets		-0.83	0.09	0.67	0.67	0.56	0.75	0.94	0.95	-0.93	-0.04	0.46	-0.71	0.95	0.11	0.54	0.39	-0.52	-0.46	-0.46	-0.63
Retained Earnings	-0.83		0.11	-0.91	-0.84	-0.21	-0.95	-0.85	-0.85	0.98	-0.37	-0.67	0.65	-0.91	0.19	-0.18	-0.45	0.69	0.52	0.52	0.78
Accounts Payable	0.09	0.11		0.06	0.22	0.63	0.03	0.32	0.23	-0.02	-0.75	-0.69	0.35	0.14	0.98	0.41	0.51	0.72	0.39	0.39	0.54
Net Receivables	0.67	-0.91	0.06		0.89	0.14	0.96	0.8	0.76	-0.88	0.36	0.53	-0.45	0.81	-0.04	0.05	0.59	-0.46	-0.46	-0.46	-0.68
Deferred Long Term Liab	0.67	-0.84	0.22	0.89		0.45	0.95	0.82	0.84	-0.84	0.03	0.5	-0.58	0.86	0.08	0.39	0.36	-0.45	-0.26	-0.26	-0.52
Total Current Assets	0.56	-0.21	0.63	0.14	0.45		0.27	0.62	0.67	-0.38	-0.82	-0.18	-0.44	0.56	0.63	0.96	0.05	0.05	0.03	0.03	0.03
Property Plant Equipment	0.75	-0.95	0.03	0.96	0.95	0.27		0.84	0.84	-0.92	0.27	0.65	-0.6	0.9	-0.08	0.22	0.44	-0.58	-0.38	-0.38	-0.67
Total Assets	0.94	-0.85	0.32	0.8	0.82	0.62	0.84		0.98	-0.94	-0.12	0.32	-0.6	0.97	0.29	0.53	0.56	-0.36	-0.44	-0.44	-0.56
Total Stockholder Equity	0.95	-0.85	0.23	0.76	0.84	0.67	0.84	0.98		-0.94	-0.15	0.42	-0.73	0.99	0.2	0.63	0.38	-0.48	-0.41	-0.41	-0.59
Current Deferred Revenue	-0.93	0.98	-0.02	-0.88	-0.84	-0.38	-0.92	-0.94	-0.94		-0.19	-0.58	0.67	-0.97	0.03	-0.34	-0.49	0.61	0.49	0.49	0.72
Net Debt	-0.04	-0.37	-0.75	0.36	0.03	-0.82	0.27	-0.12	-0.15	-0.19		0.61	-0.04	-0.01	-0.79	-0.76	0.11	-0.53	-0.38	-0.38	-0.54
Long Term Debt	0.46	-0.67	-0.69	0.53	0.5	-0.18	0.65	0.32	0.42	-0.58	0.61		-0.73	0.53	-0.74	-0.02	-0.22	-0.92	-0.37	-0.37	-0.76
Total Liab	-0.71	0.65	0.35	-0.45	-0.58	-0.44	-0.6	-0.6	-0.73	0.67	-0.04	-0.73		-0.72	0.38	-0.61	0.28	0.85	0.56	0.56	0.78
Net Invested Capital	0.95	-0.91	0.14	0.81	0.86	0.56	0.9	0.97	0.99	-0.97	-0.01	0.53	-0.72		0.1	0.52	0.4	-0.55	-0.41	-0.41	-0.64
Short Long Term Debt	0.11	0.19	0.98	-0.04	0.08	0.63	-0.08	0.29	0.2	0.03	-0.79	-0.74	0.38	0.1		0.41	0.48	0.76	0.4	0.4	0.57
Net Working Capital	0.54	-0.18	0.41	0.05	0.39	0.96	0.22	0.53	0.63	-0.34	-0.76	-0.02	-0.61	0.52	0.41		-0.2	-0.13	-0.04	-0.04	-0.07
Short Term Debt	0.39	-0.45	0.51	0.59	0.36	0.05	0.44	0.56	0.38	-0.49	0.11	-0.22	0.28	0.4	0.48	-0.2		0.27	-0.17	-0.17	-0.08
Common Stock	-0.52	0.69	0.72	-0.46	-0.45	0.05	-0.58	-0.36	-0.48	0.61	-0.53	-0.92	0.85	-0.55	0.76	-0.13	0.27		0.59	0.59	0.86
Long Term Debt Total	-0.46	0.52	0.39	-0.46	-0.26	0.03	-0.38	-0.44	-0.41	0.49	-0.38	-0.37	0.56	-0.41	0.4	-0.04	-0.17	0.59		1.0	0.86
Capital Surpluse	-0.46	0.52	0.39	-0.46	-0.26	0.03	-0.38	-0.44	-0.41	0.49	-0.38	-0.37	0.56	-0.41	0.4	-0.04	-0.17	0.59	1.0		0.86
Intangible Assets	-0.63	0.78	0.54	-0.68	-0.52	0.03	-0.67	-0.56	-0.59	0.72	-0.54	-0.76	0.78	-0.64	0.57	-0.07	-0.08	0.86	0.86	0.86

Click cells to compare fundamentals

About GeneDx Holdings Financial Statements

GeneDx Holdings shareholders use historical fundamental indicators, such as Total Assets, to determine how well the company is positioned to perform in the future. Although GeneDx Holdings investors may analyze each financial statement separately, they are all interrelated. The changes in GeneDx Holdings' assets and liabilities, for example, are also reflected in the revenues and expenses on on GeneDx Holdings' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Total Assets	482.3 M	481.6 M
Intangibles To Total Assets	0.34	0.30

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for GeneDx Stock Analysis

When running GeneDx Holdings' price analysis, check to measure GeneDx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneDx Holdings is operating at the current time. Most of GeneDx Holdings' value examination focuses on studying past and present price action to predict the probability of GeneDx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneDx Holdings' price. Additionally, you may evaluate how the addition of GeneDx Holdings to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC